BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19552632)

  • 1. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
    Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R; Horgan K
    Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
    Kim DU; Kim YH; Kim BJ; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC
    Hepatogastroenterology; 2009; 56(94-95):1395-402. PubMed ID: 19950798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
    Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and usefulness of mercaptopurine in azathioprine-intolerant Japanese patients with ulcerative colitis.
    Kuriyama M; Kato J; Suzuki H; Akita M; Hiraoka S; Okada H; Yamamoto K
    Dig Endosc; 2010 Oct; 22(4):289-96. PubMed ID: 21175481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
    Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A;
    Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Cao D; Hanauer SB
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):209-14. PubMed ID: 17296529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive drugs in Crohn's disease.
    Kornbluth A; George J; Sachar DB
    Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
    J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.
    Saibeni S; Virgilio T; D'IncĂ  R; Spina L; Bortoli A; Paccagnella M; Peli M; Sablich R; Meucci G; Colombo E; Benedetti G; Girelli CM; Casella G; Grasso G; de Franchis R; Vecchi M
    Dig Liver Dis; 2008 Oct; 40(10):814-20. PubMed ID: 18479986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
    Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
    Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation with methotrexate: underused and undervalued?
    Ruemmele FM
    Dig Dis; 2009; 27(3):312-4. PubMed ID: 19786757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.
    Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH
    Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study.
    Lau A; Chande N; Ponich T; Gregor JC
    Aliment Pharmacol Ther; 2008 Sep; 28(5):606-13. PubMed ID: 18564323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
    Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
    Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.